The purpose of this legislation is to ensure that drugs provided through the 340B drug discount program are accessible to healthcare providers and their patients. The 340B program allows certain healthcare entities, like hospitals and clinics, to purchase medications at reduced prices, which helps them serve more patients and offer a wider range of services. Key provisions of this legislation clarify that drug manufacturers must provide discounted prices to covered entities without imposing restrictions on how or where the drugs are dispensed.